Minireviews
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 105712
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.105712
Figure 1
Figure 1 Progress in the treatment of duodenal cancer. AKT: Protein kinase B; APC: Antigen-presenting cell; CTLA-4: Cytotoxic T-lymphocyte antigen 4; EGFR: Epidermal growth factor receptor; MHC: Major histocompatibility complex; mTOR: Mammalian target of rapamycin; PD-L1: Programmed death-ligand 1; PI3K: Phosphatidylinositol-3-kinase; TCR: T cell receptor; VEGF: Vascular endothelial growth factor.